Home › Funds › Foresite Capital Management VI LLC › CGON

Foresite Capital Management VI LLC position in CGON

CG ONCOLOGY INC · Health Care

Foresite Capital Management VI LLC reported holding 2,369,574 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$168.4M, representing 26.20% of its reported portfolio and ranking #1 among its reported holdings. Foresite Capital Management VI LLC has disclosed CGON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)2.37M sh
Reported value held$168.36M
Portfolio Weight26.20%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management VI LLC's CGON position evolved

Foresite Capital Management VI LLC first disclosed a stake in CGON in Q4 2024 at 2,221,474 shares (US$63.7M). The position peaked in Q2 2026 at 2,369,574 shares, worth US$168.4M. Across 7 filings, Foresite Capital Management VI LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 2,369,574 shares valued at US$168.4M — an increase of 148,100 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.22M $63.71M New
Q1 2025 2.22M $54.40M Hold
Q2 2025 2.22M $57.76M Hold
Q3 2025 2.22M $89.48M Hold
Q4 2025 2.22M $92.24M Hold
Q1 2026 2.22M $150.35M Hold
Q2 2026 2.37M $168.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has Foresite Capital Management VI LLC held CGON?

Foresite Capital Management VI LLC has disclosed CGON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Foresite Capital Management VI LLC's current position in CGON?

As of Q2 2026, Foresite Capital Management VI LLC holds 2.37M shares of CGON (CG ONCOLOGY INC), valued at $168.36M, representing 26.20% of its reported portfolio and ranking #1.

Has Foresite Capital Management VI LLC been buying or selling CGON?

In the latest 13F filing (Q2 2026), Foresite Capital Management VI LLC increased its position in CGON. The position peaked in Q2 2026 at 2.37M shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.